Letter to the Editor from Zhu and Briganti: "denosumab Safety and Efficacy among Participants in the FREEDOM Extension Study with Mild to Moderate Chronic Kidney Disease"

Jasmine Zhu; Esther M. Briganti

doi:10.1210/clinem/dgab305

Letter to the Editor from Zhu and Briganti: "denosumab Safety and Efficacy among Participants in the FREEDOM Extension Study with Mild to Moderate Chronic Kidney Disease"

Jasmine Zhu, Esther M. Briganti

School of Public Health and Preventive Medicine

Research output: Contribution to journal › Letter › Other › peer-review

1 Citation (Scopus)

Original language	English
Pages (from-to)	E2833-E2834
Number of pages	2
Journal	The Journal of Clinical Endocrinology & Metabolism
Volume	106
Issue number	7
DOIs	https://doi.org/10.1210/clinem/dgab305
Publication status	Published - 1 Jul 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1210/clinem/dgab305

Cite this

@article{41b148c90ec9496ea64ef36b07d7e804,

title = "Letter to the Editor from Zhu and Briganti: {"}denosumab Safety and Efficacy among Participants in the FREEDOM Extension Study with Mild to Moderate Chronic Kidney Disease{"}",

author = "Jasmine Zhu and Briganti, {Esther M.}",

year = "2021",

month = jul,

day = "1",

doi = "10.1210/clinem/dgab305",

language = "English",

volume = "106",

pages = "E2833--E2834",

journal = "The Journal of Clinical Endocrinology & Metabolism",

issn = "0021-972X",

publisher = "Oxford University Press, USA",

number = "7",

}

Letter to the Editor from Zhu and Briganti: "denosumab Safety and Efficacy among Participants in the FREEDOM Extension Study with Mild to Moderate Chronic Kidney Disease". / Zhu, Jasmine; Briganti, Esther M.
In: The Journal of Clinical Endocrinology & Metabolism, Vol. 106, No. 7, 01.07.2021, p. E2833-E2834.

Research output: Contribution to journal › Letter › Other › peer-review

TY - JOUR

T1 - Letter to the Editor from Zhu and Briganti

T2 - "denosumab Safety and Efficacy among Participants in the FREEDOM Extension Study with Mild to Moderate Chronic Kidney Disease"

AU - Zhu, Jasmine

AU - Briganti, Esther M.

PY - 2021/7/1

Y1 - 2021/7/1

UR - http://www.scopus.com/inward/record.url?scp=85108385786&partnerID=8YFLogxK

U2 - 10.1210/clinem/dgab305

DO - 10.1210/clinem/dgab305

M3 - Letter

C2 - 33954779

AN - SCOPUS:85108385786

SN - 0021-972X

VL - 106

SP - E2833-E2834

JO - The Journal of Clinical Endocrinology & Metabolism

JF - The Journal of Clinical Endocrinology & Metabolism

IS - 7

ER -

Letter to the Editor from Zhu and Briganti: "denosumab Safety and Efficacy among Participants in the FREEDOM Extension Study with Mild to Moderate Chronic Kidney Disease"

UN SDGs

Access to Document

Other files and links

Cite this